scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0090-4295(01)01337-1 |
P698 | PubMed publication ID | 11711373 |
P2093 | author name string | S Garg | |
J K Mellon | |||
G C Durkan | |||
R Charlton | |||
M C Robinson | |||
P H Rajjayabun | |||
P2860 | cites work | Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo | Q24324547 |
Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy | Q24539692 | ||
Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein | Q28268402 | ||
Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers | Q28287729 | ||
Evidence for a regulated interaction between heterotrimeric G proteins and caveolin | Q28304271 | ||
Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins | Q28585091 | ||
Metastasis-related genes in prostate cancer: the role of caveolin-1. | Q33715218 | ||
A detergent-free method for purifying caveolae membrane from tissue culture cells | Q33818572 | ||
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade | Q33890028 | ||
The fine structure of the gall bladder epithelium of the mouse. | Q34537858 | ||
Reduction of caveolin and caveolae in oncogenically transformed cells | Q34613343 | ||
A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling | Q36293395 | ||
Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts | Q37284379 | ||
Regulated migration of epidermal growth factor receptor from caveolae | Q40923075 | ||
Caveolae and caveolins | Q41099734 | ||
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth | Q42440094 | ||
Cell biologists explore 'tiny caves'. | Q47340307 | ||
Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1 | Q57371816 | ||
Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder Cancer | Q63966066 | ||
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells | Q74392346 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bladder cancer | Q504775 |
P304 | page(s) | 811-814 | |
P577 | publication date | 2001-11-01 | |
P1433 | published in | Urology | Q7900884 |
P1476 | title | Caveolin-1 expression is associated with high-grade bladder cancer | |
P478 | volume | 58 |
Q36343101 | Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? |
Q33872530 | Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes |
Q38980899 | CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition |
Q34010236 | Caveolae structure and function |
Q35190153 | Caveolae: mining little caves for new cancer targets |
Q40809878 | Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. |
Q38876688 | Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer |
Q34986770 | Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. |
Q36646357 | Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase |
Q37894860 | Caveolins in rhabdomyosarcoma |
Q35107630 | Cell-surface cathepsin B: Understanding its functional significance |
Q37427390 | Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders |
Q37123792 | Clinical implications of caveolins in malignancy and their potential as therapeutic targets |
Q27324084 | Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1 |
Q57351003 | Differential expression of caveolin-1 in renal neoplasms |
Q36591920 | Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines |
Q40430236 | Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma |
Q35191653 | Expression of caveolin-1 in gastrointestinal and extraintestinal cancers |
Q53649339 | Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung |
Q39332149 | Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells. |
Q47146869 | Genetic variation at the microRNA binding site of CAV1 gene is associated with lung cancer susceptibility |
Q44024860 | Genetic variations of CAV1 gene contribute to HCC risk: a case-control study |
Q42818560 | H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. |
Q34417941 | Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit |
Q54378110 | Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. |
Q36854227 | Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract. |
Q34996719 | Interaction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population |
Q33654095 | Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joining |
Q34167953 | Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo |
Q35597185 | Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment |
Q40564571 | Long-chain saturated fatty acids induce annexin II translocation to detergent-resistant membranes |
Q37436585 | MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice |
Q52585875 | Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation. |
Q34773206 | Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells |
Q47822697 | Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. |
Q33411962 | Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma |
Q34135178 | Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer |
Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
Q33763551 | Significance of talin in cancer progression and metastasis |
Q30408466 | Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer |
Q36404008 | The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions |
Q36050987 | The emerging role of the PI3-K-Akt pathway in prostate cancer progression |
Q41783109 | The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder. |
Q35163625 | The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis |
Q37542947 | The role of caveolin-1 in prostate cancer: clinical implications. |
Q34838964 | Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings |
Q38576718 | Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective |
Q35791300 | cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis |
Search more.